Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10964354 | Vaccine | 2014 | 8 Pages |
Abstract
Eventhough serological correlates of protection for yellow fever are unknown, seronegativity in vaccinated subjects may indicate primary immunisation failure, or waning of immunity to levels below the protection threshold. Immunogenicity of YFV under routine conditions of immunisation services is likely to be lower than in controlled studies. Moreover, infants and toddlers, who comprise the main target group in YF endemic regions, and populations with high HIV infection rates, respond to YFV with lower antibody levels. In those settings one booster dose, preferably sooner than currently recommended, seems to be necessary to ensure longer protection for all vaccinees.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Collaborative group for studies on yellow fever vaccines Collaborative group for studies on yellow fever vaccines,